Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
000-CUS |
Alpha Diagnostics |
Custom |
EUR 602 |
Ige Antibody Laboratories manufactures the is igm iga ige or igg more effective in circulating antibodies for neutralizing reagents distributed by Genprice. The Is Igm Iga Ige Or Igg More Effective In Circulating Antibodies For Neutralizing reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ige antibody. Other Is products are available in stock. Specificity: Is Category: Igm Group: Iga Ige
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Measles/Rubeola vaccines by ELISA |
Alpha Diagnostics |
Custom |
Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Chikungunya virus (CHIKV) by ELISA |
Alpha Diagnostics |
Custom |
Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Diphtheria Toxin/Toxoid by ELISA |
Alpha Diagnostics |
Custom |
Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Ovalbumin (Gal d2) by ELISA |
Alpha Diagnostics |
Custom |
Ask for price |
Iga Ige information
Anti-2019-nCoV S-IgM Neutralizing Antibody |
MBS2564402-01mL |
MyBiosource |
0.1mL |
EUR 420 |
Anti-2019-nCoV S-IgM Neutralizing Antibody |
MBS2564402-02mL |
MyBiosource |
0.2mL |
EUR 700 |
Anti-2019-nCoV S-IgM Neutralizing Antibody |
MBS2564402-5x02mL |
MyBiosource |
5x0.2mL |
EUR 3110 |
Anti-2019-nCoV S-IgA Neutralizing Antibody (8A5) |
EPT018 |
ELK Biotech |
50ug |
EUR 239.4 |
|
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Circulating DNA Kit |
abx098870-50rxns |
Abbexa |
50 rxns |
EUR 477.6 |
|
Circulating DNA Kit |
abx298027-50rxns |
Abbexa |
50 rxns |
EUR 477.6 |
|
Circulating DNA Kit |
AGDK-0041 |
AcceGen |
Kit |
Ask for price |
Description: Circulating DNA Kit is designed for For purification of cell-free DNA from plasma and serum samples. The kit utilizes our unique high-capacity magnetic bead technology that ensures efficient recovery of RNA fragment library within a desired fragment length range. The purified DNA is completely compatible with downstream application such as PCR, qPCR, genotyping, sequencing, Southern Blot analysis, and more. The system allows for automation after sample lysis via Hamilton STAR™, Thermo KingFisher™ Flex, Applied Biosystems® MagMAX™, Qiagen Biosprint, and other liquid handling instruments. |
Anti-2019-nCoV S-IgM Neutralizing Antibody (8A5) |
EPT006 |
ELK Biotech |
50ug |
EUR 239.4 |
|
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Horse Anti-Rabies Virus IgG (Fab2), neutralizing |
RBV16-Fab2 |
Alpha Diagnostics |
100 ul |
EUR 534 |
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody |
abx411283-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody |
abx411283-100g |
Abbexa |
100 µg |
Ask for price |
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody |
abx411283-25g |
Abbexa |
25 µg |
EUR 487.5 |
Human Cells anti-COVID-19 S-IgA Neutralizing Antibody |
DL99729A-100ul |
DL Develop |
100 ul |
EUR 299 |
|
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Human Cells anti-COVID-19 S-IgA Neutralizing Antibody |
DL99729A-50ul |
DL Develop |
50 ul |
EUR 210 |
|
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC) |
abx411284-01mg |
Abbexa |
0.1 mg |
EUR 610.8 |
|
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC) |
abx411284-100g |
Abbexa |
100 µg |
EUR 425 |
RNApure Circulating Reagent |
MBS278038-50mL |
MyBiosource |
50mL |
EUR 210 |